Literature DB >> 24825263

Cystatin C-based glomerular filtration rate estimating equations in early chronic kidney disease.

Pankaj Hari1, Lakshmy Ramakrishnan, Ruby Gupta, Rakesh Kumar, Arvind Bagga.   

Abstract

OBJECTIVE: To compare performance of combined creatinine and cystatin C-based equation with equations based on either cystatin C or creatinine alone, in early chronic kidney disease.
DESIGN: Diagnostic accuracy study.
SETTING: Tertiary-care hospital. PATIENTS: One hundred children with chronic kidney disease who underwent 99mTc diethylenetriamine pentaacetic acid (DTPA) glomerular filtration rate measurement.
METHODS: Estimating equations for glomerular filtration rate (GFR) based on serum cystatin C alone and in combination with serum creatinine were generated using regression analyses. These equations and the creatinine-based equation [0.42 x height/creatinine] were validated in 42 children with glomerular filtration rate between 60 and 90 mL/min/1.73 m2. Bias, precision and accuracy of estimating equations using DTPA glomerular filtration rate as gold standard.
RESULTS: Cystatin C-based equation (GFR=96.9 - 30.4 x cystatin) overestimated while the combined cystatin C-and creatinine-based equation [GFR=11.45 x (height/creatinine) 0.356 x (1/cystatin) 0.188] underestimated the measured GFR. Cystatin C-based equation had less bias (1.9 vs. 12.4 ml/min/1.73 m2), and higher precision (13.1 vs. 25.6 mL/min/1.73 m2) and accuracy (92.1% vs. 75.7%) than creatinine-based equation. The combined cystatin C and creatinine equation had bias (-1.4 mL/min/1.73 m2) precision (15.2 mL/min/1.73 m2) and accuracy (91.2%) similar to cystatin C-based equation.
CONCLUSIONS: Cystatin C-based equation has a better performance in estimating glomerular filtration rate than creatinine-based equation in children with early chronic kidney disease. Addition of creatinine equation does not improve the performance of the cystatin C-based equation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24825263     DOI: 10.1007/s13312-014-0400-5

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  5 in total

1.  Serum and Urinary Neutrophil Gelatinase-Associated Lipocalin Are Not Associated With Serum Redox Parameters in Amateur Athletes After an Ultramarathon.

Authors:  Adriano César Carneiro Loureiro; Gabriella Fontenele Nocrato; André Luis Lima Correia; Robson Salviano de Matos; Júlio César Chaves Nunes Filho; Elisabeth De Francesco Daher; Flávio Henrique Macedo Pinto; Ariclécio Cunha de Oliveira; Vania Marilande Ceccatto; Rodrigo Soares Fortunato; Denise Pires de Carvalho
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

2.  Effect of age, sex, and breed on serum cystatin C and creatinine concentrations in dogs.

Authors:  Naoki Iwasa; Satoshi Takashima; Tatsuo Iwasa; Rie Kumazawa; Saki Nomura; Sara Asami; Mamu Shimizu; Yui Kobatake; Naohito Nishii
Journal:  Vet Res Commun       Date:  2022-01-21       Impact factor: 2.459

3.  Comparison of three formulae for estimation of glomerular filtration rate in severely malnourished children at tertiary care facility.

Authors:  Misbah Anjum; Khemchand N Moorani; Bilquis Naeem; Shazia Kulsoom; Ashfaq Ahmed Memon
Journal:  Pak J Med Sci       Date:  2017 Nov-Dec       Impact factor: 1.088

4.  CKD-EPI creatinine-cystatin C glomerular filtration rate estimation equation seems more suitable for Chinese patients with chronic kidney disease than other equations.

Authors:  Xiao-Hua Chi; Gui-Ping Li; Quan-Shi Wang; Yong-Shuai Qi; Kai Huang; Qian Zhang; Yao-Ming Xue
Journal:  BMC Nephrol       Date:  2017-07-10       Impact factor: 2.388

5.  Evaluation of monitoring methods in asymptomatic dogs with high serum cystatin C concentrations.

Authors:  Naoki Iwasa; Satoshi Takashima; Tatsuo Iwasa; Kazuko Iwasa; Tomomi Suzuki; Rie Kumazawa; Saki Nomura; Yui Kobatake; Hitoshi Kitagawa; Naohito Nishii
Journal:  J Vet Med Sci       Date:  2019-10-15       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.